Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-small Cell Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00560573
What this trial is testing

Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 46
Early research (Phase 1)Looking for participantsNCT07181473
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Lung Cancer (NSCLC)Prostate CancerEsophageal Cancer+1 more
Phrontline Biopharma 200
Not applicableNot Yet RecruitingNCT06922266
What this trial is testing

Personalizing Adoptive Cell Transfer for Solid Tumors: Towards a New Patient-tailored Treatment Option

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ospedale San Raffaele 20
Not applicableNot Yet RecruitingNCT07661251
What this trial is testing

ITTACA (Immunotherapy Time Teller for Advanced Lung Cancer)

Who this might be right for
Non-Small Cell Lung Cancer
Laura Longshaw 60
Testing effectiveness (Phase 2)UnknownNCT03201146
What this trial is testing

Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

Who this might be right for
Lung CancerNon Small Cell Lung CancerCombination Chemotherapy+1 more
West China Hospital 48
Testing effectiveness (Phase 2)Study completedNCT00118183
What this trial is testing

Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung Cancer+5 more
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Study completedNCT00547105
What this trial is testing

Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Texas Southwestern Medical Center 24
Testing effectiveness (Phase 2)Ended earlyNCT04495894
What this trial is testing

Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma

Who this might be right for
Non-small Cell Lung CancerRenal Cell Carcinoma
Emory University 68
Early research (Phase 1)Ended earlyNCT02342353
What this trial is testing

Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)

Who this might be right for
Non-Small Cell Lung CancerNonsmall Cell Lung CancerCarcinoma, Non-Small-Cell Lung
Washington University School of Medicine 8
Not applicableStudy completedNCT00351988
What this trial is testing

Effects of Cancer Symptoms on Caregivers

Who this might be right for
Psychosocial
M.D. Anderson Cancer Center 199
Not applicableStudy completedNCT06908005
What this trial is testing

RaFIST: A Radiomics-Based Tool for Intratumoral Fibrosis Stratification in Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer - Non Small Cell
Jinling Hospital, China 508
Early research (Phase 1)Looking for participantsNCT04686305
What this trial is testing

Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

Who this might be right for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
AstraZeneca 304
Large-scale testing (Phase 3)Ended earlyNCT04588246
What this trial is testing

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more
NRG Oncology 19
Early research (Phase 1)Enrolling By InvitationNCT07218003
What this trial is testing

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Who this might be right for
Non Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more
Rondo Therapeutics 149
Testing effectiveness (Phase 2)Ended earlyNCT04844073
What this trial is testing

TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Who this might be right for
Squamous Cell Cancer of Head and Neck (SCCHN)Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer
Takeda 95
Not applicableStudy completedNCT01136083
What this trial is testing

Effect of Exercise Training on Angiogenesis and Cachexia in Lung Cancer Patients

Who this might be right for
Non-small-cell Lung Cancer
National Taiwan University Hospital 60
Not applicableStudy completedNCT05431322
What this trial is testing

Dexmedetomidine in Thoracoscopic Surgery: Opioid-Sparing Strategy

Who this might be right for
Opioid UsePostoperative Pain
Kaohsiung Veterans General Hospital. 73
Early research (Phase 1)Ended earlyNCT00268151
What this trial is testing

Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
University of Louisville 24
Early research (Phase 1)Study completedNCT00536861
What this trial is testing

Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases
Amsterdam UMC, location VUmc 11
Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Next Page